Taken together, our in vivo and in vitro data, as well as the functional studies relating to BMP-7 and gremlin reported in the literature, support a model in which the major mechanism of therapeutic action of gremlin inhibition on DN is related to the recovery of BMP-7 activity. This evidence concerns the gene BMP7 and liver dysplastic nodule.